Sign in

Research summary ·

Prunella Oral Liquid in combination with Western medical treatment for Graves' disease: A systematic review and meta-analysis.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This review pooled results from earlier trials on Graves' disease. The drug studied was Prunella Oral Liquid, a Chinese patent medicine. It is made from Prunella vulgaris. The team searched several databases up to September 2025. They found trials with 966 people in total. In each trial, people were put into groups by chance. One group got Prunella Oral Liquid plus Western care. The other group got the same Western care alone.

What they found

With antithyroid drugs, adding Prunella lowered FT3 and FT4 levels. It also raised TSH levels. It lowered TRAb and TgAb levels too. The thyroid lobes were smaller in the added group. The added group also had a lower risk of side effects. With Iodine-131, adding Prunella lowered TRAb, TgAb and TPOAb. With antithyroid drugs and food supplements, it lowered FT3 and raised TSH.

What it means for patients

The authors say adding Prunella may give extra benefit in Graves' disease. They also say the results should be read with care. They call for well-planned trials run at many centers. Such trials would need to check if it works and is safe.

Why it is not certain yet

The trust in the evidence was rated low to very low. Bias came mainly from unclear hiding of group choice. It also came from a lack of blinding. The abstract does not say how long people were followed. A review can only be as good as the studies in it.

Source

Prunella Oral Liquid in combination with Western medical treatment for Graves' disease: A systematic review and meta-analysis.

PubMed · PMID 42526549

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Graves' disease publications